Business Wire

YOKOGAWA-ELECTRIC

15.2.2024 03:01:28 CET | Business Wire | Press release

Share
Yokogawa Provides Remote Operation/Monitoring System and Video Monitoring Solution for Japan’s Largest Wind Farm

Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary Yokogawa Solution Service Corporation has completed the design, supply, and commissioning of a remote operation and monitoring system based on the OpreX™ Collaborative Information Server for the offshore wind turbines and onshore facilities at the Ishikari Bay New Port Offshore Wind Farm. The company has also contracted to provide maintenance services at this wind farm, which is operated by JERA Co., Inc. and the Green Power Investment Corporation and owned through Green Power Ishikari GK, a special-purpose corporation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240213110562/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ishikari Bay New Port Offshore Wind Farm (Source: Green Power Investment Corporation)

The Ishikari Bay New Port Offshore Wind Farm is the first wind farm in Japan to use large-scale 8,000kW wind turbines, and as of the start of commercial operations on January 1, 2024, it is the largest commercial wind farm in Japan. The remote operation and monitoring system supplied by Yokogawa includes a video system for the monitoring of all the offshore and onshore wind power generating facilities at this wind farm. On an ongoing basis, the company will also provide maintenance services for these systems.

At the core of this remote operation and monitoring system is Yokogawa’s Collaborative Information Server, a solution that offers centralized management of data from the offshore wind turbines, the transformer substation’s large-scale storage batteries, and cameras installed on the wind turbines and storage batteries, and in the turbine maintenance yard. This video monitoring system utilizes the Edge Gateway AG 10 (for indoor) solution provided by Yokogawa subsidiary amnimo Inc.

Wind is a renewable energy source, and the amount of electricity produced varies depending on weather conditions. Taking into account information on power demand provided by the transmission system operator, this remote operation and monitoring system provides the data required to control the amount of power that will be stored by the storage battery system.

In addition to the systems delivered for this project, Yokogawa Solution Service has also received orders from Green Power Investment Corporation for systems that will aggregate information in real-time from wind farms all around Japan, and link this with cloud-based analysis tools. And together with Green Power Investment, Yokogawa Solution Service has commenced proof-of-concept tests in which the DTSX3000 optical fiber temperature sensor, a product in the OpreX Field Instruments lineup, is utilized to detect signs of damage to the submarine cables at the Ishikari Bay New Port Offshore Wind Farm.

Yokogawa is firmly focused on developing the system of systems (SoS) concept, whereby systems work together as a whole while maintaining operational and management independence to achieve, in an emergent way, goals that cannot be achieved independently. While there are many types of equipment and system configurations at wind farms, Yokogawa possesses the operational technology (OT) know-how needed to interpret data from sensors and other devices and thereby identify how the equipment and systems should be linked to achieve optimization at the individual and collective levels. By leveraging this know-how to provide solutions that cover everything from operation to overall system maintenance, Yokogawa will contribute to the realization of a decarbonized society.

About Yokogawa

Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.
Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 129 companies spanning 60 countries.
For more information, visit www.yokogawa.com

The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation, or their respective holders.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240213110562/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye